Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | -1.72% | -7.72% | -19.18% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.18% | 13.09M | |
+53.34% | 63.85B | |
-2.05% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.60% | 26.52B | |
-21.39% | 18.69B | |
+2.80% | 12.73B | |
+22.71% | 12.11B | |
+27.35% | 12.07B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q1 2022 Earnings Call, May 11, 2022